Competing risk analysis of mortality from invasive cutaneous melanoma in New South Wales: A population-based study, 1988-2007

Australian and New Zealand Journal of Public Health

Volumn 36, Issue 5, 2012, Pages 441-445

  Marashi Pour, Sadaf ^a,b   Morrell, Stephen ^a,c   Cooke Yarborough, Claire ^a   Arcorace, Maria ^a   Baker, Deborah ^a  

^a Cancer Institute   (Australia)

^b NSW Ministry of Health   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Competing risks; Cutaneous melanoma; Mortality; Population based; Tumour thickness

Indexed keywords

ADULT; AGE; AGED; ARTICLE; AUSTRALIA; CANCER INVASION; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SKIN TUMOR; STATISTICAL MODEL; SURVIVAL RATE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEW SOUTH WALES; POPULATION SURVEILLANCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SKIN NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 84866980049     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-6405.2012.00912.x     Document Type: Article

References (12)

1. de Vries E, Houterman S, Janssen-Heijnen ML, et al. Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the southeast of The Netherlands. Ann Oncol. 2007;18(6):1110-6.
2. Downing A, Newton-Bishop JA, Forman D. Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003. Br J Cancer. 2006;95(1):91-5.
3. Fine J, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
4. American Joint Committee on Cancer. AJCC Cancer Staging Handbook. 7th ed. New York (NY): Springer Science & Business Media; 2009.
5. Boniol M, Armstrong BK, Dore JF. Variation in incidence and fatality of melanoma by season of diagnosis in new South Wales, Australia. Cancer Epidemiol Biomarkers Prev. 2006;15(3):524-6.
6. Berwick M, Armstrong BK, Ben-Porat L, et al. Sun exposure and mortality from melanoma. J Natl Cancer Inst. 2005;97(3):195-9.
7. Leiter U, Buettner PG, Eigentler TK, Garbe C. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society. J Clin Oncol. 2004;22(18):3660-7.
8. McKinnon JG, Yu XQ, McCarthy WH, Thompson JF. Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit. Cancer. 2003;98(6):1223-31.
9. Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD. A note on competing risks in survival data analysis. Br J Cancer. 2004;91(7): 1229-35.
10. Kivela T, Kujala E. Preenucleation radiotherapy, uveal melanoma, and competing risks. Arch Ophthalmol. 2008;126(4):580-1; author reply 581-2.
11. Berry SD, Ngo L, Samelson EJ, Kiel DP. Competing risk of death: an important consideration in studies of older adults. J Am Geriatr Soc. 2010;58(4):783-7.
12. Gooley TA, Leisenring W, Crowley J, Storer BE. Why Kaplan-Meier fails and cumulative incidence succeeds when estimating failure probabilities in the presence of competing risks. Chapter 26. In: Crowley J, editor. Handbook of Statistics in Clinical Oncology. New York (NY): Marcel Dekker; 2001. p. 513-23.